This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
05/06/16 - 9:58:29 AM ET (BATS BZX Real-time Price)
Div Yield: --
SGNT Day's Range
SGNT 52 Week Range
SGNT Business Summary
Sagent Pharmaceuticals, Inc. develops, sources, manufactures, and markets injectable pharmaceuticals in North America.View SGNT
Sagent Pharmaceuticals Inc - SGNT - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Sagent Pharmaceuticals Inc as a
Sell with a ratings score of D+.
Report Snippet: We rate SAGENT PHARMACEUTICALS INC (SGNT) a SELL. This is driven by a number of negative factors, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, poor profit margins, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share.